The wellness industry is expanding beyond traditional supplements and fitness products, with companies increasingly marketing products around longevity, metabolic health, cognitive performance, and preventive care. As brands compete to offer more specific health benefits, their advertising claims are creating new questions about scientific evidence, FDA labeling requirements, and false advertising liability.
In its July 2026 Health & Wellness Halftime Report, Fitt Insider documented an industry increasingly connecting healthcare, beauty, fitness, and technology. Its findings point to a shift in how companies position wellness products, with consumers seeking solutions that fit into broader routines for managing their health.
Recent developments in the food and beverage industry reflect that direction. In November, Poppi’s founders returned to the market with Jetty, a functional hydration brand built around electrolytes, prebiotics, and vitamins. Meanwhile, consumer lawsuits involving energy drinks, protein products, and other health-focused foods are testing whether advertised benefits match what the products and their supporting research can establish.
The legal concern extends beyond any single company. As wellness brands increasingly sell products based on what they promise to improve, the language used on packaging and in advertising becomes a central part of their potential liability.
From Longevity to Fat Burning: Wellness Products Make Bigger Promises
Wellness products are increasingly marketed around specific physical and cognitive benefits. Drinks promise metabolic support, supplements promote healthy aging, and beauty products incorporate language associated with cellular health and longevity.
These claims can help companies distinguish their products in crowded categories. They can also influence consumers to pay more for products they believe provide measurable benefits beyond ordinary nutrition or personal care.
The launch of Jetty by Poppi’s founders illustrates how functional ingredients and product positioning have become closely connected in beverage development. Jetty combines electrolytes, prebiotics, and vitamins while presenting itself as an everyday hydration option.
Its positioning reflects a broader commercial opportunity for companies seeking to appeal to health-conscious consumers. However, identifying beneficial ingredients is different from demonstrating that a finished product produces a particular health outcome.
That distinction has already become a source of litigation.
In October 2026, consumers filed lawsuits challenging Celsius’s fat-burning and metabolism claims. The plaintiffs allege that the company’s scientific research does not establish the body-fat reduction benefits consumers may understand from its advertising. Celsius disputes the allegations and maintains that its claims have scientific support; neither lawsuit has established liability.
The dispute illustrates a problem that extends to other wellness categories. Research showing that an ingredient affects a biological process may not establish that the finished product delivers the broader health benefit suggested by its marketing.
Health Claims Need More Than Promising Scientific Studies
The Federal Trade Commission requires companies to have adequate scientific evidence supporting objective health claims before advertising them. Its Health Products Compliance Guidance explains that advertisers must consider both what they expressly state and what consumers reasonably understand from their marketing.
For health-related products, this generally requires competent and reliable scientific evidence appropriate to the particular benefit being advertised.
Consider a supplement promoted for cognitive performance. A study showing that one ingredient affects certain neurological processes may support a limited statement about that ingredient. It does not automatically demonstrate that the supplement improves memory or concentration when consumed as directed.
The same distinction applies to longevity products. Research involving cellular activity or age-related biological markers does not necessarily establish that a product slows human aging or produces measurable long-term benefits.
The strength of the evidence matters, but so does its relevance to the product being sold.
Studies may involve different dosages, formulations, or participant groups from those associated with a commercial product. A manufacturer relying on that research must evaluate whether the results support the specific benefit communicated to consumers.
The FTC also examines the overall impression created by advertising. Product names, imagery, testimonials, and influencer endorsements may communicate health benefits even when a company avoids making an explicit promise.
A wellness brand could therefore face advertising liability despite carefully selecting the words on its packaging. If its promotional materials encourage consumers to expect results beyond what the research demonstrates, those implied claims may also require substantiation.
This becomes particularly important when companies use terms such as “clinically proven,” “science-backed,” or “doctor recommended.” Such expressions may communicate additional claims about the quality of the evidence or the endorsement behind a product.
When Wellness Marketing Becomes an FDA Labeling Problem
Health-related advertising also raises questions about how the FDA classifies and regulates consumer products.
The agency distinguishes between different types of claims made on conventional foods and dietary supplements. Under the FDA’s guidance on food and dietary supplement label claims, statements about supporting normal bodily functions are treated differently from certain claims connecting a substance to reduced disease risk.
For example, a dietary supplement marketed to support normal cognitive function may fall within the rules governing structure/function claims. Advertising the same product as preventing Alzheimer’s disease raises a different legal issue because disease treatment and prevention claims can bring a product within the FDA’s drug framework.
The distinction also affects functional beverages and other wellness products that borrow terminology from medical research.
Statements involving inflammation, hormone regulation, metabolic dysfunction, or cellular aging can carry different meanings depending on their wording and context. A company may intend to describe general wellness benefits while communicating a more specific medical promise to consumers.
FDA requirements also vary by product category. Dietary supplements making permissible structure/function claims generally must satisfy specific substantiation, notification, and disclaimer requirements. Conventional foods operate under different rules, including limits related to the nutritional function of ingredients.
Meeting those requirements does not necessarily eliminate exposure to consumer litigation.
A related issue has emerged in the zero-sugar lawsuits against Liquid Death and DAVID Protein, where consumers challenged how products containing allulose were marketed. FDA currently exercises enforcement discretion allowing allulose to be excluded from the Total Sugars and Added Sugars figures on Nutrition Facts labels, but separate legal questions remain about certain front-of-package sugar claims.
The lawsuits demonstrate why manufacturers cannot assume that an FDA labeling policy resolves every question about how consumers interpret a product’s advertising.
State consumer protection laws create another source of exposure. In California, for example, consumers may bring false advertising claims based on allegedly misleading product representations. Depending on the circumstances, those claims may focus on the overall impression of packaging, the price consumers paid, and whether statements influenced their purchasing decisions.
A company may therefore face challenges involving its ingredient disclosures, nutritional representations, and advertised health benefits even when those statements appear on different parts of the same product.
Strategic By Design: The Juris Law Group, P.C. Perspective
The growth of functional wellness products creates legal questions that begin well before a product reaches retail shelves. Scientific substantiation, FDA product classification, and consumer interpretation can all affect whether a company may lawfully advertise a particular health benefit. The review becomes more complex when manufacturers rely on third-party ingredient research or use similar claims across products with different formulations.
At Juris Law Group, P.C., our food and beverage attorneys address product labeling, advertising claims, and consumer protection matters involving regulated consumer products. These issues often overlap with manufacturing and distribution arrangements, particularly when responsibilities for approving packaging, maintaining substantiation records, and responding to product complaints are divided among several businesses. Such matters form part of the legal considerations involved in manufacturing, marketing, and distributing consumer products.
Over the next twelve months, the legal treatment of wellness claims may receive further attention as existing consumer lawsuits progress and new products enter the market. Disputes over metabolism and nutritional representations could provide additional guidance on how courts assess the relationship between scientific research and the benefits consumers understand from advertising.
The broader wellness industry’s continued investment in longevity, functional nutrition, and preventive health is likely to produce increasingly specific product claims. Manufacturers entering these categories will need to assess whether their scientific evidence supports those claims before incorporating them into packaging, retail listings, and promotional campaigns. As companies compete through promises of better health, the accuracy and presentation of those promises will remain central to FDA labeling exposure and false advertising litigation.
Common Legal Inquiries
Can a wellness company be sued even if scientific studies support its health claims?
Yes. Scientific research does not automatically protect a company from false advertising lawsuits. The evidence must adequately support the benefits consumers reasonably understand from the advertising. Plaintiffs may challenge whether studies involving particular ingredients, dosages, or biological effects establish the results promised by the finished product.
When do wellness product claims trigger FDA labeling or drug requirements?
The applicable requirements depend on the product category and the claims being made. Statements about supporting normal bodily functions may qualify as permissible structure/function claims, subject to applicable requirements. Claims suggesting that a product treats, prevents, or cures a disease may cause the FDA to classify it as a drug.
Can a product comply with FDA labeling rules and still face a false advertising lawsuit?
Yes. Compliance with certain FDA labeling requirements does not automatically prevent consumer lawsuits over misleading advertising. Courts may consider how consumers reasonably interpret front-of-package statements, promotional claims, and other representations. The outcome can depend on the specific claim, applicable federal and state laws, and whether the challenged state-law requirements are preempted.
